RxDoctor Payments Data

Esther Echevarria, MD

General Practice · Caguas, PRNPI 1225134745

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $694 of the $844 with a category attached, or 82.2%. Novartis accounts for 95.3% of it on its own, with 2 other manufacturers making up the rest.

$844in general payments, 2019–2025

Across 6 payments — averaging $140.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$805
  • Otsuka America Pharmaceutical, Inc.$23
  • Johnson & Johnson$16
$478,806in research payments, 2019–2025

Across 42 payments — averaging $11,400 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$310K
  • Novartis$69K
  • Merck$68K
  • Alnylam Pharmaceuticals Inc.$29K
  • Sumitomo Pharma America, Inc.$2K

What the payments were for

  • Travel & lodging$69482%
  • Food & beverage$15118%

General payments by program year

22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$844 in reported general payments places this provider in the 85th percentile of 3,586 general practice providers in Puerto Rico.

See all general practice providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$76,820
Medicare patients
121
Services billed
1,040

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium11$98

Paid to pharmacies, not to this prescriber.

Other general practice in Caguas

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →